---
schema_version: "secwatch.filing_event.v1"
accession: "0001607062-22-000196"
form_type: "8-K"
ticker: "RGBP"
cik: "0001589150"
company_name: "Regen BioPharma Inc"
filed_at: "2022-03-18T23:59:59+00:00"
generated_at: "2026-06-26T21:41:38.423485+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Regen Biopharma increases authorized common shares to 5.8B; amends preferred share classes

## Summary
- Authorized common shares increased from 4.8B to 5.8B, par value $0.0001.
- Series A Preferred authorized set at 540M shares; Series M Preferred at 60M shares.
- Total authorized capital includes 5.8B common, 540M Series A preferred, 60M Series M preferred.
- Amendment effective March 17, 2022.

## SEC filing metadata
- accession: 0001607062-22-000196
- form_type: 8-K
- ticker: RGBP
- cik: 0001589150
- company_name: Regen BioPharma Inc
- filed_at: 2022-03-18T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.03
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1589150/000160706222000196/0001607062-22-000196-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1589150/000160706222000196/rgbp031822form8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001607062-22-000196
- JSON: https://secwatch.observer/filing/0001607062-22-000196.json
- Plain text: https://secwatch.observer/filing/0001607062-22-000196.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.